KENSINGTON PARTNERSHIP — All Prescriptions & Medications
Practice Code: B83052 | BRADFORD, BD8 9LB
Over the last 12 months, KENSINGTON PARTNERSHIP prescribed 443,630 items across 773 different medications at a total cost of £3,703,352 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Eprosartan | 10 | 364 | £177 | -50.5% ▼ |
| Phenytoin | 10 | 6,000 | £360 | -8.9% ▼ |
| Dapsone | 10 | 560 | £135 | -3.2% ▼ |
| Metformin hydrochloride/sitagliptin | 10 | 798 | £141 | -73.3% ▼ |
| Canagliflozin/metformin | 10 | 560 | £349 | -33.2% ▼ |
| Ospemifene | 10 | 273 | £366 | +74.8% ▲ |
| Megestrol acetate | 10 | 364 | £226 | +45.6% ▲ |
| Cod liver oil | 10 | 300 | £48 | -20.9% ▼ |
| RtS 1.5kcal/ml m/sk, higher protein, pre-thickened (0913051) | 10 | 112.0K | £1.5K | -1.7% vs avg |
| Powder lactose free formula (0913105) | 10 | 17.6K | £270 | +24.5% ▲ |
| Tube feed additive 1 kcal/ml higher protein liquid (0914051) | 10 | 420 | £802 | -26.4% ▼ |
| Mupirocin | 10 | 36 | £48 | -14.8% ▼ |
| Sodium fusidate | 10 | 195 | £32 | +81.1% ▲ |
| 10 | 46 | £35 | +70.0% ▲ | |
| 10 | 22 | £311 | -1.5% vs avg | |
| 10 | 38 | £1.2K | +9.8% ▲ | |
| 10 | 91 | £118 | -26.4% ▼ | |
| 10 | 900 | £184 | -0.4% vs avg | |
| 10 | 870 | £3.3K | -30.1% ▼ | |
| 10 | 400 | £1.4K | +28.8% ▲ | |
| 10 | 500 | £76 | -42.7% ▼ | |
| Magnesium oxide | 11 | 1,344 | £3.7K | +27.3% ▲ |
| Diltiazem hydrochloride | 11 | 330 | £140 | +137.5% ▲ |
| Chlortalidone | 11 | 154 | £287 | +11.5% ▲ |
| Torasemide | 11 | 308 | £104 | -2.0% ▼ |
| Gemfibrozil | 11 | 616 | £372 | +8.9% ▲ |
| Alimemazine tartrate | 11 | 3,800 | £6.9K | -14.9% ▼ |
| Aspirin | 11 | 451 | £78 | +11.9% ▲ |
| Mycophenolic sodium | 11 | 616 | £814 | +12.8% ▲ |
| Leuprorelin acetate | 11 | 11 | £2.5K | -76.3% ▼ |
| Tube feed 1.2 kcal/ml with fibre (0914021) | 11 | 227.5K | £3.9K | -13.4% ▼ |
| Betamethasone sodium phosphate | 11 | 120 | £27 | +65.1% ▲ |
| 11 | 918 | £259 | +25.1% ▲ | |
| 11 | 420 | £82 | +83.0% ▲ | |
| 11 | 101 | £357 | +27.9% ▲ | |
| Disopyramide | 12 | 1,344 | £216 | +86.3% ▲ |
| Imidapril hydrochloride | 12 | 336 | £168 | -25.7% ▼ |
| Atomoxetine hydrochloride | 12 | 336 | £827 | -64.5% ▼ |
| Clindamycin hydrochloride | 12 | 422 | £86 | +19.9% ▲ |
| Acarbose | 12 | 2,016 | £553 | +2.8% ▲ |
| Ryeqo | 12 | 343 | £838 | +113.2% ▲ |
| Zinc sulfate | 12 | 1,008 | £196 | -2.6% ▼ |
| Antazoline | 12 | 120 | £38 | +170.1% ▲ |
| Ketorolac trometamol | 12 | 60 | £34 | +29.3% ▲ |
| Nepafenac | 12 | 60 | £170 | +93.2% ▲ |
| Ciprofloxacin/fluocinolone | 12 | 180 | £69 | +114.9% ▲ |
| 12 | 414 | £425 | -62.9% ▼ | |
| 12 | 225 | £898 | +145.5% ▲ | |
| 12 | 130 | £327 | +9.6% ▲ | |
| 12 | 110 | £271 | +11.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.